查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948180

全球内部神经调控设备市场：机会与策略展望（至2034年）

Internal Neuromodulation Devices Global Market Opportunities And Strategies To 2034
出版日期: | 出版商: The Business Research Company | 英文 377 Pages | 商品交期: 2-10个工作天内

价格
简介目录

全球内部神经调节设备市场预计到2024年将达到约25.946亿美元，自2019年以来以6.3%的复合年增长率成长。预计该市场将从2024年的25.946亿美元成长到2029年的40.466亿美元，成长率为9.3%，然后从2029年起继续以8.1%的复合年增长率增长，到2034年达到59.667亿美元。

植入式神经调控装置是植入式医疗设备，旨在向特定神经、脊髓通路或脑区输送靶向电刺激或化学刺激，以调节异常的神经活动。这些装置植入体内用于治疗慢性疼痛、运动障碍、癫痫以及其他神经或生理疾病。植入式神经调控装置的主要目的是恢復或调节那些对传统治疗方法反应不佳的患者的神经功能。

慢性疼痛疾病呈上升趋势

从历史上看，体内神经调控设备市场的发展一直受到慢性疼痛疾病日益普遍的推动。随着慢性疼痛的蔓延，长期药物治疗的限制（例如疗效递减、副作用和药物依赖性等问题）促使医疗专业人员和患者寻求永续的、基于设备的治疗方案。体内神经调控系统，特别是脊髓刺激设备，因其能够为慢性疼痛患者提供靶向性强、可调节且持久的治疗效果而备受关注。例如，根据美国疾病管制与预防中心（CDC）下属的国家卫生统计中心于2024年11月发布的《2023年全国健康调查》，24.3%的美国成年人（约占四分之一）在过去三个月内经历过慢性疼痛，其中8.5%的人报告称患有严重的慢性疼痛，且疼痛经常限制其日常生活或工作。报告显示，慢性疼痛盛行率从2019年的20.4%上升至7.4%，高影响慢性疼痛盛行率也呈现上升趋势，凸显了慢性疼痛疾病负担的日益恶化。因此，慢性疼痛疾病盛行率的上升正在推动体内神经调节设备市场的扩张。

专注于用于治疗癫痫和新兴适应症的MRI相容型VNS平台

内部神经调控设备市场的主要企业正日益专注于开发和推出可植入式迷走神经刺激（VNS）系统，这些系统兼容磁振造影（MRI），并核准用于除癫痫和忧郁症传统疗法之外的新治疗适应症。这一趋势旨在透过在需要时安全地进行MRI影像检查，以及将VNS的应用范围扩展到慢性神经系统疾病和发炎性疾病，使VNS疗法更加人性化。例如，2025年8月，总部位于美国的生物电子疗法开发商SetPoint Medical获得了美国食品药物管理局（FDA）对其新开发的可植入式VNS设备SetPoint食品药物管理局的批准，用于治疗对常规治疗方法核准的中重度类风湿性关节炎（RA）成人患者。这标誌着VNS的临床应用范围显着扩展到神经系统疾病之外。这表明VNS技术不仅在硬体（可植入且相容MRI）方面不断发展，而且在治疗领域也在不断拓展，凸显了将神经调控技术应用于神经系统疾病以外的慢性疾病管理的趋势。

全球内部神经调节设备市场相对分散，众多小规模企业参与其中，到 2024 年，前 10主要企业将占 34.2% 的市场份额。

目录

第一章执行摘要

第二章 目录

第三章表格一览

第四章图表一览

第五章 报告结构

第六章 市场特征

  • 一般市场定义
  • 概述
  • 内部神经调控设备市场定义与细分
  • 按类型分類的市场细分
    • 脊髓刺激设备
    • 深部脑部刺激装置
    • 荐骨神经刺激器
    • 迷走神经刺激设备
    • 胃神经刺激设备
  • 市场区隔：依生物材料划分
    • 金属生物材料
    • 高分子生物材料
    • 陶瓷生物材料
  • 市场区隔：按应用
    • 腰椎手术后症候群
    • 帕金森氏症
    • 尿失禁
    • 癫痫
    • 胃轻瘫
  • 市场区隔：依最终用户划分
    • 医院
    • 诊所
    • 居家医疗
    • 社区医学

第七章：主要市场趋势

  • 专注于用于治疗癫痫和新兴适应症的MRI相容型VNS平台
  • 开发用于治疗尿失禁的全植入式无线骶神经调节系统
  • 扩展封闭回路型与人工智慧赋能的体内神经调节系统
  • 整合定向电极以实现运动障碍的精准神经调控
  • 植入式胃刺激疗法在药物难治性胃轻瘫的应用

第八章 全球内部神经调控设备成长分析及策略分析框架

  • 全球内部神经调节设备PESTEL分析（政治、社会、技术、环境与法律因素）
    • 政治因素
    • 经济
    • 社会的
    • 技术的
    • 环境因素
    • 合法的
  • B2B市场的最终用户
    • 医院
    • 诊所
    • 居家医疗
    • 社区医学
  • 全球内部神经调控设备市场规模及成长分析
  • 2019-2024年市场成长表现
    • 2019-2024年市场驱动因素
    • 2019-2024年市场限制因素
  • 市场成长预测，2024-2029年，2034年预测
  • 预计成长要素/驱动力
    • 定量成长要素
    • 司机
    • 抑制因素
  • 全球内部神经调控设备潜在市场规模（TAM）
    • TAM比较分析

9. 全球内部神经调控设备市场：细分

  • 全球内部神经调控设备市场：依类型、性能及预测划分，2019-2024年、2029年预测、2034年预测
  • 全球内部神经调控设备市场：依生物材料、性能及预测划分，2019-2024年、2029年预测、2034年预测
  • 全球内部神经调控设备市场：依应用、效能及预测划分，2019-2024年、2029年预测、2034年预测
  • 全球内部神经调控设备市场：依最终用户划分，实际数据及预测数据，2019-2024年、2029年预测值、2034年预测值
  • 全球内部神经调控设备市场：脊髓刺激设备，依类型、表现及预测细分，2019-2024年、2029年预测、2034年预测
  • 全球内部神经调控设备市场：深部脑部刺激设备，依类型、表现及预测细分，2019-2024年、2029年预测、2034年预测
  • 全球体内神经调控设备市场：荐骨神经刺激器，依类型、表现及预测细分，2019-2024年、2029年预测、2034年预测
  • 全球体内神经调控设备市场：迷走神经刺激设备，依类型、表现及预测细分，2019-2024年、2029年预测、2034年预测
  • 全球内部神经调控设备市场：胃神经神经刺激设备，依类型、表现及预测细分，2019-2024年、2029年预测、2034年预测

第十章 内部神经调控设备市场：区域与国家分析

  • 全球内部神经调控设备市场：区域表现及预测（2019-2024年、2029年预测、2034年预测）
  • 全球内部神经调控设备市场：依国家/地区、效能和预测划分，2019-2024 年、2029 年预测、2034 年预测

第十一章 亚太市场

第十二章 西欧市场

第十三章 东欧市场

第十四章 北美市场

第十五章：南美市场

第十六章 中东市场

第十七章：非洲市场

第十八章：竞争格局与公司概况

  • 公司简介
  • Medtronic Inc
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova plc
  • Nevro Corp

第十九章：其他领先和创新企业

  • Axonics Inc.
  • NeuroPace Inc.
  • Biotronik SE & Co. KG
  • Beijing PINS Medical（PINS）
  • ONWARD Medical NV
  • Mainstay Medical International plc
  • Inspire Medical Systems Inc.
  • Synchron Inc.
  • Stimwave Technologies Incorporated
  • Blackrock Neurotech
  • INBRAIN Neuroelectronics（Inbrain）
  • Nuvectra Corporation
  • Aleva Neurotherapeutics SA
  • Second Sight Medical Products Inc.
  • Synapse Biomedical Inc.

第二十章：竞争标竿分析

第21章 竞争格局分析

第22章 重大併购

  • Globus Medical Acquired Nevro Corp.
  • Boston Scientific Acquired Axonics Inc.

第23章：植入式神经调控装置的最新趋势

  • 用于治疗帕金森氏症的自适应封闭回路型深部脑部刺激装置获得监管部门核准
  • 自动化程式设计平台核准简化SCS管理

第24章：机会与策略

  • 2029年全球内部神经调控设备市场：蕴藏新机会的国家
  • 2029年全球内部神经调控设备市场：新兴细分市场机会
  • 2029年全球内部神经调控设备市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第25章 内部神经调控设备市场：结论与建议

  • 结论
  • 建议

第26章附录

简介目录
Product Code: ME3MINDE01_O25Q4

Internal neuromodulation devices are implantable medical devices designed to deliver targeted electrical or chemical stimulation to specific nerves, spinal pathways, or brain regions, thereby modulating abnormal neural activity. These devices are placed inside the body to treat chronic pain, movement disorders, epilepsy, and other neurological or physiological conditions. The primary purpose of internal neuromodulation devices is to restore or regulate neural function in patients with conditions that do not respond adequately to conventional therapies.

The global internal neuromodulation devices market reached a value of nearly $2,594.6 million in 2024, having grown at a compound annual growth rate (CAGR) of 6.3% since 2019. The market is expected to grow from $2,594.6 million in 2024 to $4,046.6 million in 2029 at a rate of 9.3%. The market is then expected to grow at a CAGR of 8.1% from 2029 and reach $5,966.7 million in 2034.

Rising Prevalence Of Chronic Pain Disorders

During the historic period, the internal neuromodulation devices market was driven by the rising prevalence of chronic pain disorders. As chronic pain became more widespread, limitations of long-term pharmacological management, including declining effectiveness, side effects, and dependency concerns, pushed clinicians and patients to seek durable, device-based solutions. Internal neuromodulation systems, particularly spinal cord stimulators, gained traction as they offered targeted, adjustable, and sustained therapeutic effects for individuals living with persistent pain. For instance, in November 2024, according to the US Centers for Disease Control and Prevention (CDC), a US-based National Center for Health Statistics, in 2023 National Health Interview Survey, 24.3% of US adults (about 1 in 4) reported chronic pain in the past 3 months and 8.5% reported high-impact chronic pain that frequently limited life or work activities. The same report noted that this represented an increase from 20.4% with chronic pain and 7.4% with high-impact chronic pain in 2019, illustrating a rising burden of chronic pain disorders over time Therefore, the internal neuromodulation devices market was driven by the rising prevalence of chronic pain disorders.

Focus On MRI-Compatible VNS Platforms For Epilepsy And New Indications

Major companies in the internal neuromodulation devices market are increasingly emphasizing the development and regulatory introduction of implantable Vagus Nerve Stimulation System (VNS) platforms that are MRI (magnetic resonance imaging)-compatible and cleared for newer therapeutic indications beyond classic epilepsy or depression. This trend aims to make VNS therapy more patient-friendly, by enabling safe access to MRI imaging when needed, and by expanding the use of VNS for chronic neurological or inflammatory diseases. For example, in August 2025, SetPoint Medical, a US-based company develops bioelectronic therapies, newly developed implantable VNS device, SetPoint System, was approved by the US Food and Drug Administration (FDA) for use in adults with moderate-to-severe Rheumatoid Arthritis (RA) who had failed conventional therapies. This represents a meaningful expansion of clinical use for VNS beyond neurological disorders. This shows how VNS technology is evolving, not just on the hardware front (implantable, MRI-compatible), but also in therapeutic positioning, aligning neuromodulation with chronic disease management beyond neurology.

The global internal neuromodulation devices market is fairly fragmented, with large number of small players operating in the market. The top ten competitors in the market made up to 34.2% of the total market in 2024.

Internal Neuromodulation Devices Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global internal neuromodulation devices market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for internal neuromodulation devices? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The internal neuromodulation devices market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider internal neuromodulation devices market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics: - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by biomaterial, by application and by end-user.
  • Key Trends: - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework: - Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Global Market Size And Growth: - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis: - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation: - Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by type, by biomaterial, by application and by end-user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth: - Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape: - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies: - Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking: - Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard: - Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions: - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments: - Information on recent developments in the market covered in the report
  • Market Opportunities And Strategies Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations This section includes recommendations for internal neuromodulation devices providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix: - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Type: Spinal Cord Stimulator; Deep Brain Stimulator; Sacral Nerve Stimulator; Vagus Nerve Stimulator; Gastric Neuro Stimulator
  • 2) By Biomaterial: Metallic Biomaterials; Polymeric Biomaterials; Ceramic Biomaterials
  • 3) By Application: Failed Back Surgery Syndrome; Parkinson's Disease; Urinary Incontinence; Epilepsy; Gastroparesis
  • 4) By End-User: Hospitals; Clinics; Home Healthcare; Community Healthcare
  • Companies Mentioned: Medtronic plc; Abbott Laboratoriesl; Boston Scientific Corporation; LivaNova plc; Nevro Corp
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; internal neuromodulation devices comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes."

Table of Contents

1 Executive Summary

  • 1.1 Internal Neuromodulation Devices - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Internal Neuromodulation Devices Market Definition And Segmentations
  • 6.4 Market Segmentation By Type
    • 6.4.1 Spinal Cord Stimulator
    • 6.4.2 Deep Brain Stimulator
    • 6.4.3 Sacral Nerve Stimulator
    • 6.4.4 Vagus Nerve Stimulator
    • 6.4.5 Gastric Neuro Stimulator
  • 6.5 Market Segmentation By Biomaterial
    • 6.5.1 Metallic Biomaterials
    • 6.5.2 Polymeric Biomaterials
    • 6.5.3 Ceramic Biomaterials
  • 6.6 Market Segmentation By Application
    • 6.6.1 Failed Back Surgery Syndrome
    • 6.6.2 Parkinson's Disease
    • 6.6.3 Urinary Incontinence
    • 6.6.4 Epilepsy
    • 6.6.5 Gastroparesis
  • 6.7 Market Segmentation By End-User
    • 6.7.1 Hospitals
    • 6.7.2 Clinics
    • 6.7.3 Home Healthcare
    • 6.7.4 Community Healthcare

7 Major Market Trends

  • 7.1 Focus On MRI-Compatible VNS Platforms For Epilepsy And New Indications
  • 7.2 Development Of Fully Implantable, Wireless SNM Systems For Incontinence Therapy
  • 7.3 Expansion of Closed-Loop and AI-Enabled Internal Neuromodulation Systems
  • 7.4 Integration Of Directional Leads For Precision Neuromodulation In Movement Disorders
  • 7.5 Adoption Of Implantable Gastric Stimulation For Drug-Resistant Gastroparesis

8 Global Internal Neuromodulation Devices Growth Analysis And Strategic Analysis Framework

  • 8.1 Global Internal Neuromodulation Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
    • 8.1.1 Political
    • 8.1.2 Economic
    • 8.1.3 Social
    • 8.1.4 Technological
    • 8.1.5 Environmental
    • 8.1.6 Legal
  • 8.2 End Users of B2B Market
    • 8.2.1 Hospitals
    • 8.2.2 Clinics
    • 8.2.3 Home Healthcare
    • 8.2.4 Community Healthcare
  • 8.3 Global Internal Neuromodulation Devices Market Size And Growth Analysis
  • 8.4 Historic Market Growth, 2019 - 2024, Value ($ Million)
    • 8.4.1 Market Drivers 2019 - 2024
    • 8.4.2 Market Restraints 2019 - 2024
  • 8.5 Forecast Market Growth, 2024 - 2029, 2034F Value ($ Million)
  • 8.6 Forecast Growth Contributors/Factors
    • 8.6.1 Quantitative Growth Contributors
    • 8.6.2 Drivers
    • 8.6.3 Restraints
  • 8.7 Global Internal Neuromodulation Devices Total Addressable Market (TAM)
    • 8.7.1 TAM Comparison Analysis

9 Global Internal Neuromodulation Devices Market Segmentation

  • 9.1 Global Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.2 Global Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.3 Global Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.4 Global Internal Neuromodulation Devices Market, Segmentation By End-User, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.5 Global Internal Neuromodulation Devices Market, Sub-Segmentation Of Spinal Cord Stimulator, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.6 Global Internal Neuromodulation Devices Market, Sub-Segmentation By Deep Brain Stimulator, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.7 Global Internal Neuromodulation Devices Market, Sub-Segmentation By Sacral Nerve Stimulator, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.8 Global Internal Neuromodulation Devices Market, Sub-Segmentation By Vagus Nerve Stimulator, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 9.9 Global Internal Neuromodulation Devices Market, Sub-Segmentation By Gastric Neuro Stimulator, By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

10 Internal Neuromodulation Devices Market, Regional and Country Analysis

  • 10.1 Global Internal Neuromodulation Devices Market, By Region, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 10.2 Global Internal Neuromodulation Devices Market, By Country, Historic and Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

11 Asia-Pacific Market

  • 11.1 Summary
  • 11.2 Market Overview
    • 11.2.1 Region Information
    • 11.2.2 Market Information
    • 11.2.3 Background Information
    • 11.2.4 Government Initiatives
    • 11.2.5 Regulations
    • 11.2.6 Regulatory Bodies
    • 11.2.7 Major Associations
    • 11.2.8 Taxes Levied
    • 11.2.9 Corporate Tax Structure
    • 11.2.10 Investments
    • 11.2.11 Major Companies
  • 11.3 Asia Pacific Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.4 Asia Pacific Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.5 Asia Pacific Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.6 Asia-Pacific Internal Neuromodulation Devices Market: Country Analysis
  • 11.7 China Market
  • 11.8 Summary
  • 11.9 Market Overview
    • 11.9.1 Country Information
    • 11.9.2 Market Information
    • 11.9.3 Background Information
    • 11.9.4 Government Initiatives
    • 11.9.5 Regulations
    • 11.9.6 Regulatory Bodies
    • 11.9.7 Major Associations
    • 11.9.8 Taxes Levied
    • 11.9.9 Corporate Tax Structure
    • 11.9.10 Major Companies
  • 11.10 China Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.11 China Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.12 China Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.13 India Market
  • 11.14 India Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.15 India Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.16 India Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.17 Japan Market
  • 11.18 Summary
  • 11.19 Market Overview
    • 11.19.1 Country Information
    • 11.19.2 Market Information
    • 11.19.3 Background Information
    • 11.19.4 Government Initiatives
    • 11.19.5 Regulations
    • 11.19.6 Regulatory Bodies
    • 11.19.7 Major Associations
    • 11.19.8 Taxes Levied
    • 11.19.9 Corporate Tax Structure
    • 11.19.10 Major Companies
  • 11.20 Japan Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.21 Japan Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.22 Japan Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.23 Australia Market
  • 11.24 Australia Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.25 Australia Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.26 Australia Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.27 Indonesia Market
  • 11.28 Indonesia Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.29 Indonesia Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.30 Indonesia Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.31 South Korea Market
  • 11.32 Summary
  • 11.33 Market Overview
    • 11.33.1 Country Information
    • 11.33.2 Market Information
    • 11.33.3 Background Information
    • 11.33.4 Government Initiatives
    • 11.33.5 Regulations
    • 11.33.6 Regulatory Bodies
    • 11.33.7 Major Associations
    • 11.33.8 Taxes Levied
    • 11.33.9 Corporate Tax Structure
    • 11.33.10 Investments
    • 11.33.11 Major Companies
  • 11.34 South Korea Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.35 South Korea Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 11.36 South Korea Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

12 Western Europe Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate tax structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Western Europe Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.4 Western Europe Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.5 Western Europe Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.6 Western Europe Internal Neuromodulation Devices Market: Country Analysis
  • 12.7 UK Market
  • 12.8 UK Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.9 UK Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.10 UK Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.11 Germany Market
  • 12.12 Germany Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.13 Germany Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.14 Germany Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.15 France Market
  • 12.16 France Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.17 France Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.18 France Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.19 Italy Market
  • 12.20 Italy Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.21 Italy Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.22 Italy Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.23 Spain Market
  • 12.24 Spain Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.25 Spain Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 12.26 Spain Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

13 Eastern Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Major companies
  • 13.3 Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.4 Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.5 Eastern Europe Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.6 Eastern Europe Internal Neuromodulation Devices Market: Country Analysis
  • 13.7 Russia Market
  • 13.8 Russia Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.9 Russia Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 13.10 Russia Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

14 North America Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Investments
    • 14.2.11 Major Companies
  • 14.3 North America Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.4 North America Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.5 North America Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.6 North America Internal Neuromodulation Devices Market: Country Analysis
  • 14.7 USA Market
  • 14.8 Summary
  • 14.9 Market Overview
    • 14.9.1 Country Information
    • 14.9.2 Market Information
    • 14.9.3 Background Information
    • 14.9.4 Government Initiatives
    • 14.9.5 Regulations
    • 14.9.6 Regulatory Bodies
    • 14.9.7 Major Associations
    • 14.9.8 Taxes Levied
    • 14.9.9 Corporate Tax Structure
    • 14.9.10 Investments
    • 14.9.11 Major Companies
  • 14.10 USA Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.11 USA Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.12 USA Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.13 Canada Market
  • 14.14 Summary
  • 14.15 Market Overview
    • 14.15.1 Country Information
    • 14.15.2 Market Information
    • 14.15.3 Background Information
    • 14.15.4 Government Initiatives
    • 14.15.5 Regulations
    • 14.15.6 Regulatory Bodies
    • 14.15.7 Major Associations
    • 14.15.8 Taxes Levied
    • 14.15.9 Corporate Tax Structure
    • 14.15.10 Investments
    • 14.15.11 Major Companies
  • 14.16 Canada Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.17 Canada Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 14.18 Canada Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

15 South America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Major Companies
  • 15.3 South America Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.4 South America Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.5 South America Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.6 South America Internal Neuromodulation Devices Market: Country Analysis
  • 15.7 Brazil Market
  • 15.8 Brazil Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.9 Brazil Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 15.10 Brazil Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

16 Middle East Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Major Companies
  • 16.3 Middle East Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.4 Middle East Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 16.5 Middle East Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

17 Africa Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Major Companies
  • 17.3 Africa Internal Neuromodulation Devices Market, Segmentation By Type, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.4 Africa Internal Neuromodulation Devices Market, Segmentation By Biomaterial, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)
  • 17.5 Africa Internal Neuromodulation Devices Market, Segmentation By Application, Historic And Forecast, 2019 - 2024, 2029F, 2034F, Value ($ Million)

18 Competitive Landscape And Company Profiles

  • 18.1 Company Profiles
  • 18.2 Medtronic Inc
    • 18.2.1 Company Overview
    • 18.2.2 Products And Services
    • 18.2.3 Business Strategy
    • 18.2.4 Financial Overview
  • 18.3 Abbott Laboratories
    • 18.3.1 Company Overview
    • 18.3.2 Products And Services
    • 18.3.3 Business Strategy
    • 18.3.4 Financial Overview
  • 18.4 Boston Scientific Corporation
    • 18.4.1 Company Overview
    • 18.4.2 Products And Services
    • 18.4.3 Business Strategy
    • 18.4.4 Financial Overview
  • 18.5 LivaNova plc
    • 18.5.1 Company Overview
    • 18.5.2 Products And Services
    • 18.5.3 Business Strategy
    • 18.5.4 Financial Overview
  • 18.6 Nevro Corp
    • 18.6.1 Company Overview
    • 18.6.2 Products And Services
    • 18.6.3 Business Strategy
    • 18.6.4 Financial Overview

19 Other Major And Innovative Companies

  • 19.1 Axonics Inc.
    • 19.1.1 Company Overview
    • 19.1.2 Products And Services
  • 19.2 NeuroPace Inc.
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
  • 19.3 Biotronik SE & Co. KG
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
  • 19.4 Beijing PINS Medical (PINS)
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
  • 19.5 ONWARD Medical NV
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
  • 19.6 Mainstay Medical International plc
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
  • 19.7 Inspire Medical Systems Inc.
    • 19.7.1 Company Overview
    • 19.7.2 Products And Services
  • 19.8 Synchron Inc.
    • 19.8.1 Company Overview
    • 19.8.2 Products And Services
  • 19.9 Stimwave Technologies Incorporated
    • 19.9.1 Company Overview
    • 19.9.2 Products And Services
  • 19.10 Blackrock Neurotech
    • 19.10.1 Company Overview
    • 19.10.2 Products And Services
  • 19.11 INBRAIN Neuroelectronics (Inbrain)
    • 19.11.1 Company Overview
    • 19.11.2 Products And Services
  • 19.12 Nuvectra Corporation
    • 19.12.1 Company Overview
    • 19.12.2 Products And Services
  • 19.13 Aleva Neurotherapeutics SA
    • 19.13.1 Company Overview
    • 19.13.2 Products And Services
  • 19.14 Second Sight Medical Products Inc.
    • 19.14.1 Company Overview
    • 19.14.2 Products And Services
  • 19.15 Synapse Biomedical Inc.
    • 19.15.1 Company Overview
    • 19.15.2 Products And Services

20 Competitive Benchmarking

21 Competitive Dashboard

22 Key Mergers And Acquisitions

  • 22.1 Globus Medical Acquired Nevro Corp.
  • 22.2 Boston Scientific Acquired Axonics Inc.

23 Recent Developments In Internal Neuromodulation Devices

  • 23.1 Adaptive Closed-Loop Deep Brain Stimulator Gains Regulatory Approval For Parkinson's Therapy
  • 23.2 Automated Programming Platform Approved To Simplify SCS Management

24 Opportunities And Strategies

  • 24.1 Global Internal Neuromodulation Devices Market In 2029 - Countries Offering Most New Opportunities
  • 24.2 Global Internal Neuromodulation Devices Market In 2029 - Segments Offering Most New Opportunities
  • 24.3 Global Internal Neuromodulation Devices Market In 2029 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Internal Neuromodulation Devices Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer